Strata advised the shareholders of Melbourn Scientific Limited

Transaction Summary

Strata advised the shareholders of Melbourn Scientific Limited, a specialist pharmaceutical products testing business, on its sale to Intertek Group plc, a leading quality solutions provider to industries worldwide.

Background

• Strata acted as exclusive financial adviser to the shareholders of Melbourn Scientific Limited (“Melbourn” or the “Company”) on its sale to Intertek Group plc, a leading quality solutions provider to industries worldwide

• Melbourn, a specialist pharmaceutical products testing business, is a privately owned UK company based near Cambridge where it employs over 80 scientists and staff

• The Company has built a strong reputation over the last 24 years providing world class testing and formulation services to the international pharmaceutical industry, with a focus on the testing and evaluation of nasally and orally inhaled drugs and their delivery systems such as inhalers and nebulisers

• Strata was hired because of our proven track record and established senior relationships across the global pharma services sector

Transaction Highlights

• Strata structured, managed and successfully completed the transaction securing an exceptionally good result for shareholders at valuation substantially above that indicated by potential purchasers prior to Strata’s involvement

• Benefiting from its established sector relationships, Strata rapidly and discretely secured the interest of key potential purchasers worldwide – thereby ensuring competitive tension from the outset

• Meticulous planning and preparation, first class transaction execution and senior commitment and support were critical to ensuring a successful and timely outcome

• This is our 14th successful M&A transaction in the life science services and laboratory testing sector and underlines our position as Europe’s leading corporate finance advisory boutique in this space